COVID-19 RESPONSE - We are committed to supporting our scientific community during this pandemic. Learn more 

Coronavirus SARS-CoV-2 (COVID-19) Vaccine Research

Common applications in COVID-19 and infectious disease research including vaccines, therapeutics and diagnostics

Global research efforts are focused on understanding the SARS-CoV-2 virus in order to develop potential therapies for COVID-19 including:

  • vaccines
  • recombinant proteins, including monoclonal antibodies
  • repurposing of drug molecules already approved, or in clinical trials, for other viruses
  • developing diagnostic and research tools using antibodies

Here we've addressed common applications in infectious disease research including cell line development, binding affinity, viral neutralization, viral titer and more.

Common application for infectious disease research

 

 

Optimized workflow for rapid identification of neutralizing antibodies against viral particles

In this on-demand webinar, you will learn:

  • CloneSelect™ Single Cell Printer for gently depositing a single cell into a well with the entire cell deposition process imaged and time-stamped
  • Combined Single Cell Printer and CloneSelect™ Imager workflow to provide high assurance of monoclonality in a single round of cloning
  • The single cell deposition- and outgrowth-efficiency comparisons using single cell printer, flow cytometry and limiting dilution
  • ClonePix™ with monoclonality assurances provides a complete automated workflow for screening tens of thousands of clones while including confirmation of clonality
Register now

 

 

Accelerating study of viral infection and therapeutics

In this on-demand webinar, you will learn:

  • How to integrate microplate reader detection and high-content screening workflows for detection of viral infectivity, investigation of viral mechanism of action, and screening of therapies
  • How to use high-throughput screening to analyze multiple parameters across RNAi, therapeutic vaccine, and antibody screens
  • How to determine viral infectivity TCID50 through fluorescence, luminescence, or absorbance-based microplate detection platforms
  • How to establish robust assays across multiple platforms for high-throughput detection of viral infectivity with microplate detection and high-content imaging applications
Register now

 

SARS-CoV-2 key applications

Learn more about how our technology and solutions can help support your research of COVID-19 cellular responses and vaccine development.

Resources related to COVID-19 cellular responses and vaccine development

Videos & Webinars

Optimized workflow for rapid identification of neutralizing antibodies against viral particles

Accelerating study of viral infection and therapeutics with microplate-based detection and high-throughput screening

Systems to accelerate your COVID-19 cellular response and vaccine development

We have validated and compliant laboratory solutions including microplate readers, microplate washers, biopharma and cellular imaging systems to meet your research needs.